Bipolar disorder, major depression and schizophrenia are severe brain disorders. No biological hallmark has been identified for any of these disorders. Here, we report that abnormal X chromosome inactivation (XCI) often presents in lymphoblastoid cells of female patients with different major psychiatric disorders in the general population. X chromosome inactivation is well preserved in human lymphoblastoid cells. XIST, KDM5C, and other X-linked genes are over-expressed in the lymphoblastoid cells of female patients, suggesting an abnormal XCI. Trimethylation of lysine 27 on histone 3 (H3K27me3) is significantly increased at both XIST and KDM5C gene loci. We found that XIST and KDM5C expression can be used as a potential diagnostic hallmark for major psychiatric disorders in a large sub-population of female patients. Preliminary studies also suggest an increased XIST expression in postmortem brains from female patients with schizophrenia, bipolar disorder, and major depression. An
Introduction
Schizophrenia, major depression and bipolar disorder are severe brain disorders. The biological basis of these major psychiatric disorders has been little understood. Our previous studies found that inhibition of protein translation may contribute to pathogenesis of major psychiatric disorders in a rare Scottish family (Ji et al., 2014) . Conversely, excessive protein translation has been suggested in fragile X syndrome and autism (Santoro et al., 2012) . We speculate that abnormal protein translation may contribute to a wide range of mental disorders not only in rare families, but also in the general population.
It is impossible to directly measure protein translation activity in the human brain. However, there are some genes that can affect protein translation in both lymphocytes and neurons; for example, mutation of FMR1 causes excessive protein translation in both lymphoblastoid cells and the brain (Bhakar et al., 2012; Gross and Bassell, 2012) . Therefore, we analyzed protein translation activity in psychiatric patients' lymphoblastoid cells in hope of validating our hypothesis and finding more susceptibility genes. We observed a significantly larger variation in protein translation activity in the patients' lymphoblastoid cells than in the cells of healthy controls. Surprisingly, all variations in protein translation activity came from the female patients. These findings prompted us to investigate functions of the X chromosome in the female patients' lymphoblastoid cells. We examined X chromosome inactivation (XCI) by quantifying expression of XIST and several other X-linked genes in the lymphoblastoid cells of patients with different psychiatric disorders. A preliminary study of XIST expression was conducted in the postmortem brains of patients with schizophrenia, bipolar disorder, and major depression. Finally, chromatin immunoprecipitation was performed to examine abnormalities of epigenetic modifications of the X chromosome.
Results

Abnormal protein translation activity in lymphoblastoid cells from patients with severe mania and psychosis
Protein translation activity was examined in the lymphoblastoid cells of psychiatric patients. To synchronize cell growth, lymphoblastoid cells were first serum-starved for 8 h before re-stimulated with a normal concentration of serum. Protein translation activity was measured 8 h after serum re-stimulation using the SUnSET (surface sensing of translation) method (Ji et al., 2014; Schmidt et al., 2009 ).
Different protein translation activities were observed between cell lines ( Figure 1A ). After analyzing 26 healthy controls and 28 patients with severe mania and psychosis, we found a significantly larger variation in protein translation activity in the patients' lymphoblastoid cells ( Figure 1B ). To rule out whether variations in protein translation activity measured by SUnSET may come from differential puromycin uptake between cell lines, we quantified the intracellular concentrations of puromycin using a modified quantification method (Fujiwara et al., 1982) . We selected two cell lines (B25 and B27) with a marked difference in SUnSET ( Figure 1C ). The concentration of intracellular puromycin in each cell line was quantified by the effectiveness of its cell lysate to block the interactions between anti-puromycin antibodies and immobilized puromycin-containing proteins on the Western blot membrane. Western blot signal was gradually decreased after adding an increasing amount of cell lysate to the blocking solution ( Figure 1C ). There was no difference between the blocking activities of B25 and B27 cell lysate, indicating that there is a comparable concentration of intracellular puromycin between the two cell lines.
We conclude that different SUnSET intensities between B25 and B27 likely come from differential activities of protein synthesis. We also conducted SUnSET experiments in asynchronous proliferating lymphoblastoid cells. There was a high correlation of SUnSET intensities between the proliferating cells and the synchronized cells (data not shown). No correlation was found between individuals' age and protein translation activity ( Figure S1A ). When the SUnSET data were sub-grouped according to gender, however, we found that all variation in protein translation activity came from the female patients ( Figure   1D ). To avoid potential bias in the normalization of SUnSET data between gels, we re-ran females'
SUnSET on the same Western blot gel. Larger variation in protein translation activity was confirmed in the female patients ( Figure S1B ).
XCI dysregulation in female patients with severe mania and psychosis.
Restriction of abnormal protein translation activity to the female patients' lymphoblastoid cells prompted us to investigate potential dysregulation of sex chromosome functions. We examined XCI in female lymphoblastoid cells by quantifying expression of XIST (Brown et al., 1992) , TSIX (Migeon et al., 2002) , FTX (Chureau et al., 2002) , and JPX (Chureau et al., 2002) genes. All of these genes produce noncoding RNAs (ncRNA) and are localized at the core of the X chromosome inactivation center (XIC).
Their mouse orthologs play central roles in establishing XCI (Brockdorff et al., 1992; Chureau et al., 2011; Lee et al., 1999; Tian et al., 2010) . We found that expression of XIST is significantly higher (p = 0.001, FDR corrected for multiple comparisons) in the female patients than in the female controls ( Figure 2A ).
In contrast to high XIST expression, TSIX expression is significantly lower (p < 0.01, FDR corrected for multiple comparisons) in the patients' cells ( Figure 2B ). We also observed a trend of high expression of FTX (p < 0.1, FDR corrected for multiple comparisons) in the patients ( Figure 2C ), but no difference was found in JPX expression ( Figure 2D ). In mouse, Xist expression is negatively regulated by Tsix, but positively regulated by Ftx and Jpx (Chureau et al., 2011; Lee et al., 1999; Tian et al., 2010) . Consistent with the negative role of mouse Tsix, human TSIX expression is lower in the patients' cells that display higher XIST expression. However, there is only a modest linear negative correlation between human XIST and TSIX expression ( Figure 2E) . TSIX may play different roles in human from its mouse ortholog Tsix (Migeon et al., 2002) . There is a modest negative correlation between human TSIX and FTX expression ( Figure S2A ), consistent with the opposite roles proposed for mouse Tsix and Ftx genes in the regulation of Xist expression. Taken together, altered expression of XIST and its possible regulator genes within XIC indicates an abnormal XCI in the lymphoblastoid cells of the female patients.
Abnormal XCI may affect expression of other X-linked genes beyond XIC. We randomly selected a few genes that are either completely inactivated by or escapees from XCI. PGK1, G6PD and HPRT1 genes have been known to be inactivated by XCI, and KDM5C, KDM6A and RPS4X genes are the well-established escapees from XCI in human lymphoblastoid cells (Johnston et al., 2008) . We found that expression of KDM5C is significantly higher (p < 0.05, FDR corrected for multiple comparisons) in the female patients than in the female controls ( Figure 3A ). There is a trend of high expression of KDM6A, PGK1 and G6PD genes (p < 0.1, uncorrected) in the patients' cells before correction of multiple comparisons ( Figure 3B, 3C, 3D) . No difference was found in expression of either HPRT1 or RPS4X gene between the patients and the controls ( Figure S2B, S2C) . KDM5C and KDM6A genes encode different histone H3 lysine-specific demethylases that play key roles in chromatin remodeling Lan et al., 2007; Lee et al., 2007; Tahiliani et al., 2007) . A strong positive correlation (Pearson's coefficient, r = 0.88) was observed between KDM5C and KDM6A expression ( Figure 3E ).
Interestingly, XIST and KDM5C expression also display a strong positive correlation ( Figure   3F )(Pearson's coefficient, r = 0.78). We explored whether a combination of XIST and KDM5C expression can be used as a potential diagnostic marker to separate the patients from the controls.
According to calculation of reference range in clinical blood tests (William J. Marshall, 2008) , we calculated the reference ranges of XIST and KDM5C expression in the control females to define a "normal" distribution. The upper limit of the reference range is defined as 1.96 standard deviations above the mean (dashed line, Figure 3F ). Out of 13 patients, 8 have XIST and/or KDM5C expression above their reference ranges.
To investigate whether female patients' medication histories may potentially alter expression of XIST, TSIX, KDM5C and KDM6A genes in their later established lymphoblastoid cells, we examined expression of these genes in lymphoblastoid cells after treatment of the antipsychotics clozapine (CLZ) and the mood stabilizer valproic acid (VPA). None of these genes displayed altered expression after a combined treatment of CLZ and VPA ( Figure S3A , S3B, S3C, S3D). These data suggest that female patients' medication histories (if any) are unlikely to have any effect on the expression of XIST, KDM5C
and other genes in their lymphoblastoid cells. Additionally, expression of KDM5C and KDM6A genes was not altered in the lymphoblastoid cells of male patients in comparison with the healthy male controls ( Figure S4 ), supporting that patients' medication history has no effect on expression of X-linked genes in their lymphoblastoid cells. Neither XIST nor KDM5C expression is affected by age ( Figure S5A , S5B).
We investigated whether abnormal XCI may be responsible for more variation in protein translation activity in the female patients' lymphoblastoid cells. There is no correlation between XIST expression and protein translation activity (SUnSET) ( Figure S5C ). A weak correlation between KDM5C expression and SUnSET was observed ( Figure S5D ). We speculate that other modifier genes on autosomes, which conceivably vary between individuals, may also be involved in the regulation of protein translation.
XCI dysregulation in female patients with recurrent major depression.
We are particularly interested in the finding of abnormal XCI in the lymphoblastoid cells of some bipolar female patients with mania and psychosis. To investigate whether abnormal XCI presents in a different psychiatric disorder, we examined expression of XIST, TSIX, KDM5C, KDM6A, PGK1, and G6PD genes in the lymphoblastoid cells of female patients with recurrent major depression. These genes were chosen because they displayed significant or trend of increases of expression in patients with mania and psychosis. We found that expression of XIST is significantly higher (p < 0.001, FDR corrected for multiple comparisons) in the female patients with recurrent major depression than in the female healthy controls ( Figure 4A ). In contrast to significant reduction of TSIX expression in the female patients with mania and psychosis, down-regulation of TSIX expression was not statistically significant in the lymphoblastoid cells of female patients with recurrent major depression ( Figure 4B ). It is possible that the sample size of the patients may be too small to have a sufficient statistical power to detect a smaller difference. Expression of KDM5C is also significantly higher (p < 0.001, FDR corrected for multiple comparisons) in the patients with recurrent major depression ( Figure 4C ). Consistent with a trend of high KDM6A expression in female patients with mania and psychosis, we observed a significantly higher expression of KDM6A (p < 0.05, FDR corrected for multiple comparisons) in the lymphoblastoid cells of female patients with recurrent major depression ( Figure 4D ). However, no difference was found in either PGK1 or G6PD expression between the female patients and healthy controls ( Figure S6A , S6B). As expected, a strong positive correlation (Pearson's coefficient, r = 0.85) was observed between KDM5C and KDM6A expression ( Figure 4E ). XIST expression is also highly correlated with KDM5C expression (Pearson's coefficient, r = 0.85)( Figure 4F ). After calculating the reference ranges of XIST and KDM5C expression in the healthy controls, 8 out of 10 patients have XIST expression above the upper limit of its reference range.
We next examined expression of KDM5C and KDM6A proteins in female patients with recurrent major depression. Western blot analyses confirmed a significantly higher level of KDM5C protein (p < 0.01) in the patients' cells than in the controls' cells ( Figure 5A , 5B). A modest correlation between the levels of KDM5C RNA and KDM5C protein was observed (Pearson's coefficient, r = 0.53)( Figure 5C ).
Conceivably, protein expression is not solely controlled by the level of RNA expression (Schwanhausser et al., 2011) . Western blot detected a weaker signal for KDM6A protein ( Figure S6C) . A significantly higher level of KDM6A proteins was also observed in the patients (p < 0.05)( Figure S6D ). No correlation between KDM6A RNA and KDM6A protein expression was detected ( Figure S6E ). We also measured protein translation activity in the female patients' cells using SUnSET. A significantly larger variation of protein translation activity was also observed in the lymphoblastoid cells of female patients with recurrent major depression (data not shown).
A steady-state level of XIST expression
To investigate whether cell passages may alter expression of XIST, KDM5C, and KDM6A genes, we collected batches of cells from different cell passages and analyzed expression of these genes. The level of XIST expression is very stable between different cell passages ( Figure 6A ). There is a high correlation of XIST expression (Pearson's coefficient, r = 0.88) in individual cell lines between the two different cell passages. Despite more variation in KDM5C expression ( Figure 6B ), there is still a strong correlation between the two different cell passages (Pearson's coefficient, r = 0.6). In contrast to XIST and KDM5C expression, KDM6A expression appeared to be more affected by variations from different cell cultures ( Figure S7A ).
To address potential lack of representativeness of the small sample size of the female controls, we enlarged the control sample size by including more healthy females. Because we ran out of female European Caucasian controls, we analyzed expression of XIST, KDM5C and KDM6A genes in a group of healthy females with mixed ethnic backgrounds. There is no difference in either XIST or KDM5C expression between the European Caucasian female controls and the female controls with mixed ethnic backgrounds ( Figure S7B , S7C). A slightly higher expression of KDM6A gene was observed in the controls with mixed ethnic backgrounds ( Figure S7D ). Considering that KDM6A expression is more susceptible to variations of different cell cultures, it is not surprising that its expression can be affected by different ethnic backgrounds. Since there is no ethnic effect on either XIST or KDM5C expression, we combined the two groups of healthy female controls together. We have demonstrated that female patients with either mania and psychosis or recurrent major depression display over-expression of both XIST and KDM5C genes. Therefore, we combined the two groups of female patients together and examined their XCI again. As expected, XIST expression displays a narrow distribution in the combined female controls ( Figure 6C ). A significantly higher XIST expression was observed in the combined female patients (p <
10
-6 , FDR corrected for multiple comparisons) than in the combined female controls. Females with Triple X syndrome (XXX), although rare, have a high XIST expression. We did not find any of our controls or patients with triple X chromosomes ( Figure S7E ). There is also a significantly higher KDM5C expression in the combined female patients (p < 10 -4 , FDR corrected for multiple comparisons)( Figure   6D ). With an increased sample size of healthy controls, more accurate reference ranges were calculated for both XIST and KDM5C expressions. 16 out of 23 patients displayed high XIST (11 patients) and/or KDM5C (12 patients) expression above their reference ranges ( Figure 6E ). Considering that the female patients and the female controls were randomly collected from the general population, it is likely that a significantly large sub-population of female patients from the general population may have abnormal XCI.
In a limited number of postmortem human brains, we examined expression of XIST, TSIX, KDM5C, and KDM6A genes in the cortical RNA of female patients with schizophrenia, bipolar disorder, and major depression (kindly provided by Stanley Medical Research Institute). Due to small sample sizes, we did not expect to detect group differences in gene expression. We rather focused on identifying individuals who may display abnormal XCI. Despite the small sample size of female controls' postmortem brains, the distribution range of XIST expressions is very similar to the one calculated from the combined controls' lymphoblastoid cells. In the postmortem brains, the upper limit (1.279) of the reference range of XIST expression is close to the one (1.26) calculated from the combined controls' lymphoblastoid cells, confirming little variation of XIST expression among healthy individuals. Several female patients display higher XIST expression above the upper limit (1.279) of its reference range in the postmortem brains ( Figure 6F ). We noticed that one bipolar patient displayed a lower XIST expression.
TSIX expression in the 6 patients who have the highest XIST expression is significantly lower than that in the rest of population ( Figure S7F ), supporting potentially abnormal XCI in these patients' brains. In 
Increased trimethylation of lysine 27 on histone 3 (H3K27me3) on the X chromosome in female patients' lymphoblastoid cells
H3K27me3 is particularly enriched on the inactive X chromosome because of Xist-dependent recruitment of Polycomb repressor complex 2 (PRC2) that methylates lysine 27 on histone 3 (Maenner et al., 2010; Plath et al., 2003; Zhao et al., 2008) . Over-expression of XIST may increase H3K27me3 on the inactive X chromosome in female patients' lymphoblastoid cells. However, we observed over-expression of XIST, KDM5C and other X-linked genes in the patients. H3K27me3 was therefore examined around the promoters of XIST and KDM5C genes using chromatin immunoprecipitation. Out of 6 randomly selected sites at the promoter of XIST gene, XIST (1) and XIST (3) sites have significantly more abundant H3K27me3 in the patients' lymphoblastoid cells than in the controls' lymphoblastoid cells ( Figure 7A ).
A trend of more H3K27me3 was observed at XIST (4) in the patients. Consistent with more H3K27me3 on the XIST gene, KDM5C gene also displayed more abundant H3K27me3 at KDM5C (1) in the patients' lymphoblastoid cells ( Figure 7B ). H3K27me3 enrichment at some loci appears to correlate well with the level of gene expression ( Figure 7C, 7D, 7E ). These data provided further support to the abnormal XCI in female patients' lymphoblastoid cells.
Discussion
Lymphoblastoid cells have been used to identify differential gene expressions as potential biomarkers for psychiatric disorders. However, these studies have been questioned for their relevance to psychiatric disorders due to lack of justification of commonality between lymphoblastoid cells and the brain. XCI is unique. It occurs early during embryogenesis in all somatic cells to ensure the same gene dosage from X chromosome between males and females (Lee and Bartolomei, 2013) . XCI is very stable and well preserved in human lymphoblastoid cells (Johnston et al., 2008; Zhang et al., 2013) , providing a convenient cell model to study XCI effects in human disease (Amir et al., 2000) . Therefore, we consider abnormal XCI observed in patients' lymphoblastoid cells to reflect the same abnormality of XCI in all somatic cells including the brain. Our preliminary studies of a limited number of postmortem human brains support the conclusion.
In mouse, Xist is a master gene in the initiation of XCI (Kay et al., 1993; Penny et al., 1996; Plath et al., 2002) . Tsix, Ftx, and Jpx genes, localized in X chromosome inactivation center (XIC), have been demonstrated to regulate expression of Xist (Chureau et al., 2011; Lee et al., 1999; Tian et al., 2010) . In human lymphoblastoid cells, we observed a significantly higher XIST expression in the patients with either mania and psychosis or recurrent major depression. Alteration of TSIX and FTX expression was less robust, but consistent with the regulatory roles proposed for their mouse orthologs. However, there may be species difference in the mechanisms of regulation; for example, human TSIX was reported to be co-expressed with XIST from the same inactivated X chromosome in contrast to mouse Tsix that expresses only in the active X chromosome (Migeon et al., 2002) . Alteration of gene expression caused by abnormal XCI spreads beyond XIC in the female patients. Out of 6 randomly selected genes outside of XIC, KDM5C and KDM6A genes displayed significantly higher expression in female patients' lymphoblastoid cells. Disinhibition of X-linked gene expression suggested a deficient XCI in the female patients' lymphoblastoid cells. Unexpectedly, we observed more abundant H3K27me3, an epigenetic silencing marker on the inactive X chromosome (Plath et al., 2003) , at both XIST and KDM5C genes in the female patients' lymphoblastoid cells. It is possible that H3K27me3 level may also be altered at other X-linked genes. How can we reconcile excessive H3K27me3 at these genes with their over-expression in the patients' lymphoblastoid cells? One possible scenario could be that over-expression of XIST may result from disinhibition of X-linked genes by deficient XCI. Excessive XIST RNA recruits more PRC2
to increase H3K27me3 at XIST, KDM5C, and other genes on the inactive X chromosome. Although
H3K27me3 is a negative cue that can be recognized by other repressors such as PRC1 to silence gene expression, H3K27me3 does not alter chromatin structure per se to suppress gene expression (Margueron and Reinberg, 2011) . Increased H3K27me3, therefore, may not necessarily be sufficient to suppress expression of X-linked genes in female patients' lymphoblastoid cells. Although H3K27me3 is in general a repressive marker, it may play an active role in expression of some set of genes (Young et al., 2011) .
There is another possibility that over-expression of XIST may cause, rather than a consequence of, deficient XCI. For example, excessive H3K27me3 generated by XIST overexpression may interfere with establishment of insulators (Phillips-Cremins and Corces, 2013; Van Bortle et al., 2012; Weth et al., 2014) and thereby compromise the organization of inactive X chromosome structure to disinhibit expression of X-linked genes. In addition to XIST-PRC2 in the regulation of H3K27me3, KDM6A that demethylates . We did not find any Triple X syndrome patients in our samples. In Triple X syndrome, all escapee genes on the extra inactive X chromosome are presumably over-expressed. In the female patients (XX) we analyzed, however, not all escapee genes (e.g. RPS4X) were over-expressed. Increased expression of X-inactivated genes was also observed in some patients with mania and psychosis. Therefore, there may be differences in the over-dosage of Xlinked genes between Triple X syndrome and the female patients (XX) with abnormal X chromosome inactivation. Therefore, we posit that over-dosage of some X-linked genes could cause major psychiatric disorders in female patients with a normal karyotype (46, XX). Interestingly, mutation of KDM5C gene was reported to cause X-linked syndromic mental retardation (Tahiliani et al., 2007) ; however, functions of its over-expression remain unknown.
It is interesting that XIST has a steady-state level of high expression and correlates well with KDM5C gene expressions in individual cell lines across different cell passages. These observations suggest that human XIST may still have a functional role beyond the establishment of XCI, presumably in maintenance of XCI. To support our hypothesis, mouse Xist was demonstrated to be essential for maintenance of XCI (Yildirim et al., 2013) . However, the role of XIST/Xist expression is less understood in the maintenance than in the initiation of XCI. It is unlikely that TSIX, FTX, and JPX genes play a major role in the maintenance of XIST expression because of lack of robust correlations between expression of XIST and expression of any of these genes.
Our studies suggest that there is an abnormal XCI in female patients' lymphoblastoid cells, which may disinhibit expression of X-linked genes. We do not assume that the same set of X-linked genes affected by abnormal XCI will display the same alteration of expression between the patients' lymphoblastoid cells and brains since cell-specific regulators will also contribute to alteration of their expression. Therefore, consequence of abnormal XCI on gene expression in patients' brain remains unknown, which is likely more relevant to development of major psychiatric disorders in females.
Abnormal XCI has been observed in patients with either mania and psychosis or recurrent major depression. How could the abnormality of XCI result in markedly different clinical symptoms? One explanation could be that psychiatric disorders are not distinct individual diseases, but a spectrum of mental disorders. For example, some patients display both mania and depression. The same chromosome translocation associates with schizophrenia, major depression, and other psychiatric disorders in a Scottish family (St Clair et al., 1990 ). Another explanation is that abnormal XCI may interact with other modifier genes on autosomes and environment to result in different clinical symptoms. In psychiatric genetics, no single genetic locus has been found to carry a high risk and affect a significantly large portion of the general population of patients. It has been assumed that men and women share common genetic risk factors. The X chromosome is often omitted in GWAS studies (Wise et al., 2013) .
Surprisingly, we showed that a large subpopulation of female psychiatric patients from the general population may actually have a different genetic cause or pathway (XCI) from men. We would argue that this subpopulation of female patients may be better defined biologically as a "XIST disorder" rather than being categorized into different psychiatric disorders according to their clinical symptoms. Identification of a subpopulation of "XIST disorder" with a common genetic and biological causality could accelerate scientific research, and provide objectivity in clinical diagnosis as well as a biological target for development of treatment.
Many questions remain to be answered. We found abnormal protein translation in the as a potential biomarker. Therefore, we shifted our focus to the investigation of abnormal XCI that could be a biological cause as well as a potential biological hallmark for major psychiatric disorders in some females.
The number of genetic factors regulating XIST/Xist expression in initiation of XCI, a fundamental biological process during embryogenesis, remain incompletely understood (Lee, 2011) . It was reported that mouse Xist expression quickly reaches a high level to initiate XCI and maintains the same high level across later development (Buzin et al., 1994) and between different adult tissues (Kay et al., 1993; Ma and Strauss, 2005 
Materials and Methods
Lymphoblastoid cell culture
Studies on human lymphoblastoid cells were conducted under a University of California San Diego IRBapproved protocol. All lymphoblastoid cell lines were kindly provided by Dr. John R. Kelsoe at UCSD.
The cells were in their early passages (< 20 passages) (Oh et al., 2013) . Demographic information of the subjects is summarized in Table 
Protein translation activity
Lymphoblastoid cells were serum-starved for 8 h to synchronize cell growth. 8 h after addition of serum,
SUnSET was conducted to measure instant protein translation activity as described (Ji et al., 2014) .
Patient and control samples were loaded alternately on PAGE gels regardless of age and gender. Because of differential overall intensities between different gels in western blot analyses, the signal of each sample was first normalized against the average intensity of all samples from the same gel. After normalization, samples were analyzed according to diagnosis, gender, and age. To confirm a larger variation of protein translation activity in female patients, female samples were re-run on the same Western blot gel to rule out potential bias introduced by normalization between gels.
Quantification of intracellular puromycin concentration
Puromycin-labeled protein used to quantify intracellular concentrations of puromycin in lymphoblastoid cells was prepared as follows: HEK293T cells were labeled with puromycin for 20 minutes (Ji et al., 2014) . Cells were collected and sonicated in passive lysis buffer (Promega, WI) with 1X protease IgG (dilution at 1:10,000, Cell signaling, MA) for 1.5 hr at room temperature. Pierce ECL Western blot substrate (Pierce, IL) was used to visualize the signal. Quantification of Western blot bands was conducted using Image J.
RNA from postmortem human brains
We received 57 BA7 cortical RNA samples out of 60 brains from Stanley Medical Research Institute (SMRI), consisting of 15 each diagnosed with schizophrenia, bipolar disorder, or major depression, and 15 unaffected controls. 21 out of 57 samples were females. The four groups were matched by age, sex, race, postmortem interval, pH, hemisphere, and mRNA quality (http://www.stanleyresearch.org/dnn/Default.aspx?tabid=196).
Quantitative real-time RT-PCR
Total RNA was extracted from lymphoblastoid cells with TRIzol reagent (Invitrogen, Carlsbad, CA).
Primers were selected to amplify exons without alternative splicing in order to quantify all RNA isoforms.
All PCR primers were first confirmed to specifically amplify the target cDNA genes without background before being used for QPCR. cDNA was synthesized from 5ug of total RNA using Superscript III FirstStrand Synthesis System (Invitrogen, Carlsbad, CA) with random hexamers. SYBR Green real-time PCR was used to quantify relative expression of all genes with a comparative Ct method. The standard curve of PCR amplification was examined. All amplifications had R 2 >0.99. Amplification efficiency for each pair of primers was determined using known molecular concentration of template DNA. Each sample had 4 amplification replica wells. After amplification, Ct was set in the exponential amplification phase of the curve as recommended by the manufacturer's protocol (Bio-Rad CFX384). Variation of cycles between amplification replica wells was smaller than 0.5 cycles. β-actin was used as a reference control for normalization. In most cases, relative expression of each gene in each sample was presented as a percentage relative to the mean of the control group. The following primers were used in real-time QPCR:
1. β-actin 
Data analysis
All data were first tested for normal distribution using the Kolmogorov−Smirnov test. SUnSET intensity of individual samples was normalized against β-actin. To avoid differential overall intensity between the gels, the intensity of each sample is presented as a percentage of the average intensity of all samples from the same gel. A significantly larger variation of protein translation activity was observed in the patients than in the controls (p < 0.01, F-test). Each dot represents a human subject (black=healthy controls; red=patients). CTRL: controls; BP: bipolar patients with mania and psychosis. background were included in analysis of XIST expression. Since both depression and mania patients display the same abnormal XCI, they were combined in analyses. Significantly higher XIST expression (t(57)=-6.06, p < 10 -6 , unpaired, two-tailed student's t-test, FDR corrected for multiple comparisons) was found in the combined group of patients than in the combined group of the healthy controls. (D) KDM5C also displayed significantly higher expression (t(57)=-4.51, p < 10 -4 , unpaired, two-tailed student's t-test,
